Skip to main content
Medika d.d. logo

Medika d.d. — Investor Relations & Filings

Ticker · MDKA ISIN · HRMDKARA0000 LEI · 74780000O0R8ZVGJJO27 ZSE Wholesale and retail trade
Open in API
Filings indexed 804 across all filing types
Latest filing 2025-02-28 Financial Supplement Da…
Country HR Croatia
Listing ZSE MDKA

About Medika d.d.

https://www.medika.hr/en/

Medika d.d. is a pharmaceutical wholesale company specializing in the sale, storage, and distribution of products for the healthcare sector. The company's primary activities encompass the supply of a broad range of goods, including human and veterinary drugs, medical products, dental supplies, and various types of equipment. In addition to its core pharmaceutical distribution, Medika's portfolio also includes dietetic, cosmetic, and hygienic products. The company provides comprehensive logistics and distribution services to a diverse client base within the healthcare market.

Recent filings

Filing Released Lang Actions
tfi-pod-eur-Grupa Medika-hrv_4Q 2024.xlsx
Financial Supplement Data
2025-02-28 Croatian
Grupa Medika d.d. Privremeni Financijski Izvještaji 31.12.2024..pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Međuizvještaj poslovodstva' (Management Interim Report) for the Medika Group for the year 2024, specifically covering the fourth quarter. It includes a management commentary, key events, and detailed financial statements (Balance Sheet/Bilanca). Since it provides comprehensive financial data for a period shorter than a full fiscal year (Q4 2024) and is not merely an announcement, it is classified as an Interim/Quarterly Report. Q4 2024
2025-02-28 Croatian
tfi-pod-eur-Medika-hrv_4Q 2024.xlsx
Financial Supplement Data
2025-02-28 Croatian
Medika d.d. Privremeni Financijski Izvještaji 31.12.2024..pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Međuizvještaj poslovodstva' (Management Interim Report) for Medika d.d. covering the fourth quarter of 2024. It includes management commentary, key events, and a structured table labeled 'Tromjesečni financijski izvještaji' (Quarterly Financial Reports). Although it explicitly states the figures are 'privremene' (provisional) and 'nerevidirane' (unaudited), it contains substantive financial and operational data for the period, fitting the definition of an Interim/Quarterly Report (IR). Q4 2024
2025-02-28 Croatian
Održana sjednica Uprave 28.02.2025.pdf
Audit Report / Information Classification · 95% confidence The document is a short announcement (806 characters) from MEDIKA d.d. dated February 28, 2025. The subject is 'PREDMET – ODRŽANA SJEDNICA UPRAVE' (SUBJECT – BOARD MEETING HELD). The text explicitly states that the Board of Directors acknowledged the provisional, unaudited annual non-consolidated and consolidated financial statements for the period 01.01.-31.12.2024. This is not the full financial report itself (like a 10-K or IR), but rather an announcement that the management has reviewed and accepted the preliminary annual results. This fits the description of an Earnings Release (ER) which is the initial announcement of periodical financial results (key highlights only), or potentially a Regulatory Filing (RNS) if it doesn't meet the ER criteria. Since it announces the *acknowledgement* of the annual results, ER is a strong candidate, but given the context of acknowledging *preliminary* annual results, it often precedes the formal release. However, based on the definitions, ER covers the initial announcement of periodical financial results. Since this is an announcement regarding the *acceptance* of the annual figures by the board, it functions as a precursor or summary announcement of the annual results. Given the brevity and the nature of announcing the review of annual figures, ER is the most appropriate fit among the specific financial announcement types, although it is not the full report itself. If it were purely announcing *when* the report would be released, RPA would apply. Since it announces the *content* (the figures were reviewed), ER is chosen over RNS. FY 2024
2025-02-28 Croatian
Najava sjednice Uprave 28.02.2025.pdf
Regulatory Filings Classification · 95% confidence The document is very short (792 characters) and its primary purpose is to announce a future event, specifically a meeting of the Management Board ('Uprave Društva') scheduled for 28.02.2025. The agenda for this meeting includes the review of 'Privremeni financijski izvještaji' (Interim financial statements) for the period 01.01.-31.12.2024. Since this is an announcement about an upcoming internal event/decision-making process rather than the release of the final report itself, and it doesn't fit the specific categories like ER (Earnings Release) or IR (Interim Report), it falls best under a general regulatory announcement or a notice related to management/governance activities. Given the content is a formal notice ('NAJAVA SJEDNICE') about reviewing year-end results, it is a regulatory filing/notice. It is not a Call Transcript (CT), Earnings Release (ER), or Interim Report (IR) because it is only announcing the *meeting* where those items will be discussed, not releasing the results themselves. It is closest to a general regulatory filing (RNS) or potentially related to management/governance, but RNS is the safest fallback for formal notices not covered elsewhere. However, since it is a formal notice about a management board meeting, it is a specific type of regulatory disclosure. Given the options, RNS (Regulatory Filings) is the most appropriate general category for formal, non-standard disclosures like meeting announcements.
2025-02-25 Croatian

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.